Literature DB >> 7683034

Expression of Thy-1 on human hematopoietic progenitor cells.

W Craig1, R Kay, R L Cutler, P M Lansdorp.   

Abstract

Expression of Thy-1 on hematopoietic cells from human fetal liver (FL), cord blood (CB), and bone marrow (BM) was studied with a novel anti-Thy-1 antibody, 5E10. Specificity of 5E10 for human Thy-1 was demonstrated by immunoprecipitation of a 25-35-kD molecule, and the sequence of a cDNA that was cloned by immunoselection of COS cells transfected with a cDNA library derived from a 5E10+ cell line. Two- and three-color immunofluorescence staining experiments revealed that the Thy-1 expression is restricted to, an average, 1-4% of FL, CB, and BM cells, and binding to these cell types is essentially restricted to a very small subset of lymphoid cells and approximately 25% of CD34+ cells. Thy-1+ CD34+ cells were further characterized as CD38lo/CD45RO+/CD45RA-/CD71lo/c-kit(lo) and rhodamine 123dull. When CD34+ cells were sorted on the basis of Thy-1 expression, the majority of clonogenic cells were recovered in the CD34+Thy-1- fraction, whereas the majority of cells capable of producing myeloid colonies after 5-8 wk of long-term culture (long-term culture initiating cells) were recovered in the Thy-1+CD34+ fraction. In addition to CD34+ cells, Thy-1 was found to be expressed on a variable, very small number (< 1%) of CD34- mononuclear cells in BM, CB, and peripheral blood that were further characterized as CD3+ CD4+ lymphocytes. The restricted expression of Thy-1 on primitive hematopoietic cells is in agreement with a previous report (Baum et al., 1992. Proc. Natl. Acad. Sci. USA. 89:2804) in which Thy-1 expression was used to enrich for primitive hematopoietic cells from fetal tissue. Compared with those previous studies, we found Thy-1 expression on a larger proportion of CD34+ cells (25% in our study vs. 5% in Baum et al.) and furthermore performed studies on Thy-1 expression on CD34+ cells from CB, FL, and BM in relation to markers that are known to be differentially expressed on hematopoietic cells. Taken together our results indicate that Thy-1-specific antibody 5E10 is an attractive tool for further studies on the biology and purification of human stem cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683034      PMCID: PMC2191025          DOI: 10.1084/jem.177.5.1331

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers.

Authors:  H J Sutherland; P M Lansdorp; D H Henkelman; A C Eaves; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

2.  Rapid synthesis and cloning of complementary DNA from any RNA molecule into plasmid and phage M13 vectors.

Authors:  R G Rutledge; V L Seligy; M J Côté; K Dimock; L L Lewin; M P Tenniswood
Journal:  Gene       Date:  1988-08-15       Impact factor: 3.688

3.  Sequential expression of CD34 and CD33 antigens on myeloid colony-forming cells.

Authors:  H J Bühring; B Asenbauer; K Katrilaka; G Hummel; F W Busch
Journal:  Eur J Haematol       Date:  1989-02       Impact factor: 2.997

4.  Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro.

Authors:  H J Sutherland; C J Eaves; A C Eaves; W Dragowska; P M Lansdorp
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

5.  Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.

Authors:  J Brandt; E F Srour; K van Besien; R A Briddell; R Hoffman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

6.  Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines.

Authors:  H L Ostergaard; D A Shackelford; T R Hurley; P Johnson; R Hyman; B M Sefton; I S Trowbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  Phenotypic analysis of mouse hematopoietic stem cells shows a Thy-1-negative subset.

Authors:  G J Spangrude; D M Brooks
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

8.  Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow.

Authors:  P M Lansdorp; H J Sutherland; C J Eaves
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

9.  Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties.

Authors:  R G Andrews; J W Singer; I D Bernstein
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations.

Authors:  J T Kemshead; L Heath; F M Gibson; F Katz; F Richmond; J Treleaven; J Ugelstad
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

View more
  73 in total

1.  Localization of CD44 and CD90 positive cells to the invasive front of breast tumors.

Authors:  Vera S Donnenberg; Albert D Donnenberg; Ludovic Zimmerlin; Rodney J Landreneau; Rohit Bhargava; Ryan A Wetzel; Per Basse; Adam M Brufsky
Journal:  Cytometry B Clin Cytom       Date:  2010-04-30       Impact factor: 3.058

2.  Association of CD34+ and CD90+ Stem Cells of Cord Blood with Neonatal Factors: A Cross-sectional Study.

Authors:  Santwana Mantri; E Venkata Rao; Pradeep Kumar Jena; Prakash Chandra Mohapatra
Journal:  Indian J Pediatr       Date:  2015-08-07       Impact factor: 1.967

3.  Zonal hierarchy of differentiation markers and nestin expression during oval cell mediated rat liver regeneration.

Authors:  Sarah Koenig; Irmelin Probst; Heinz Becker; Petra Krause
Journal:  Histochem Cell Biol       Date:  2006-07-12       Impact factor: 4.304

4.  Phenotypic and functional comparison of two distinct subsets of programmable cell of monocytic origin (PCMOs)-derived dendritic cells with conventional monocyte-derived dendritic cells.

Authors:  Babak Beikzadeh; Nowruz Delirezh
Journal:  Cell Mol Immunol       Date:  2015-02-09       Impact factor: 11.530

5.  Thy-1 as a potential novel diagnostic marker for gastrointestinal stromal tumors.

Authors:  Despoina Oikonomou; Kambiz Hassan; Jussuf T Kaifi; Henning C Fiegel; Paulus G Schurr; Uta Reichelt; Kuniaki Aridome; Emre F Yekebas; Oliver Mann; Dietrich Kluth; Tim Strate; Jakob R Izbicki
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-30       Impact factor: 4.553

6.  Isolation and therapeutic potential of human haemopoietic stem cells.

Authors:  Andrew D Clark; Heather G Jørgensen; Joanne Mountford; Tessa L Holyoake
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

7.  Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood.

Authors:  Ravindra Majeti; Christopher Y Park; Irving L Weissman
Journal:  Cell Stem Cell       Date:  2007-12-13       Impact factor: 24.633

8.  Absence of CD4 or CD8 lymphocytes changes infiltration of inflammatory cells and profiles of cytokine expression in skin wounds, but does not impair healing.

Authors:  Lin Chen; Nisha D Mehta; Yan Zhao; Luisa A DiPietro
Journal:  Exp Dermatol       Date:  2014-03       Impact factor: 3.960

Review 9.  Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges.

Authors:  Ching-Shwun Lin; Zhong-Cheng Xin; Jican Dai; Tom F Lue
Journal:  Histol Histopathol       Date:  2013-04-16       Impact factor: 2.303

10.  A human endogenous retrovirus suppresses translation of an associated fusion transcript, PLA2L.

Authors:  P E Kowalski; D L Mager
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.